alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
|                                                 |   |                             |   |                                         |
|------------------------------------------------------|--------|----------------------------------|--------|----------------------------------------------|
| Delaware(STATE OR OTHERJURISDICTION OFINCORPORATION) |   | 001-11241(COMMISSION FILENUMBER) |   | 37-1105865(IRS EMPLOYERIDENTIFICATIONNUMBER) |

|                                                                                                                               |   |   |   |   |
|------------------------------------------------------------------------------------------------------------------------------------|--------|--------|--------|--------|
| 2120 West End Avenue, Nashville, Tennessee    37203-0001(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)    (ZIP CODE) |

----

|    |   |                                                            |
|---------|--------|-----------------------------------------------------------------|
| Exhibit |   |                                                            |
| Number  |   | Description                                                     |
| 5.1     |   | Opinion of Sidley Austin LLP, as to the legality of the Notes.  |
|    |   |                                                            |
| 23.1    |   | Consent of Sidley Austin LLP (included as part of Exhibit 5.1). |
|    |   |                                                            |

----

|   |   |                                       |   |                                                         |   |   |
|--------|--------|--------------------------------------------|--------|--------------------------------------------------------------|--------|--------|
|   |   | Caterpillar Financial Services Corporation |   |                                                         |
|   |   |                                       |   |                                                         |   |   |
|   |   | By:                                        |   | /s/ J. Wesley Blumenshine                                    |   |   |
|   |   |                                       |   |                                                         |   |   |
|   |   |                                       |   | Name: J. Wesley BlumenshineTitle:   Secretary |   |   |

----

|    |   |                                                            |
|---------|--------|-----------------------------------------------------------------|
| Exhibit |   |                                                            |
| Number  |   | Description                                                     |
| 5.1     |   | Opinion of Sidley Austin LLP, as to the legality of the Notes.  |
|    |   |                                                            |
| 23.1    |   | Consent of Sidley Austin LLP (included as part of Exhibit 5.1). |
|    |   |                                                            |

----
Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Digital Insight Corporation (the Company) on Form 10-Q for the period ended June 30, 2006 as
filed with the Securities and Exchange Commission on the date hereof (the Report), I, Jeffrey E. Stiefler, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial
condition and results of operation of the Company.



|                                                                           
|---------------------------------------------------------------------------
|                                                                           
|/s/ Jeffrey E. Stiefler                                                    
|Jeffrey E. Stiefler                                                        
|Chairman of the Board, President and Chief Executive Officer August 7, 2006

A signed original of this written statement required by Section 906 has been provided to
Digital Insight and will be retained by Digital Insight and furnished to the Securities and Exchange Commission or its staff upon request.
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
<CIK>   0001037120
<NAME>  LOOMIS, FARGO & CO.
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JUN-30-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                           4,530
<SECURITIES>                                         0
<RECEIVABLES>                                   41,126
<ALLOWANCES>                                   (5,170)
<INVENTORY>                                      2,068
<CURRENT-ASSETS>                                56,275
<PP&E>                                          76,151
<DEPRECIATION>                                  30,555
<TOTAL-ASSETS>                                 216,898
<CURRENT-LIABILITIES>                           49,771
<BONDS>                                        165,320
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           100
<OTHER-SE>                                     (2,544)
<TOTAL-LIABILITY-AND-EQUITY>                   216,898
<SALES>                                        174,738
<TOTAL-REVENUES>                               174,738
<CGS>                                                0
<TOTAL-COSTS>                                  170,283
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               7,287
<INCOME-PRETAX>                                (2,832)
<INCOME-TAX>                                       106
<INCOME-CONTINUING>                            (2,938)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                  (124)
<CHANGES>                                            0
<NET-INCOME>                                   (3,062)
<EPS-PRIMARY>                                   (0.03)
<EPS-DILUTED>                                   (0.03)
        

</TABLE>
From: rtholman@charter.net

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 2:39:25 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Rosie Holman

Birmingham, AL 35226
[Federal Register Volume 88, Number 185 (Tuesday, September 26, 2023)]
[Notices]
[Pages 66058-66059]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-20772]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to The National Cooperative Research and 
Production Act of 1993--National Armaments Consortium

    Notice is hereby given that, on July 7, 2023, pursuant to section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), National Armaments Consortium 
(``NAC'') has filed written notifications simultaneously with the 
Attorney General and the Federal Trade Commission disclosing changes in 
its

[[Page 66059]]

membership. The notifications were filed for the purpose of extending 
the Act's provisions limiting the recovery of antitrust plaintiffs to 
actual damages under specified circumstances. Specifically, Action 
Engineering, LLC, Golden, CO; Adolf Meller Co dba Meller Optics Inc, 
Providence, RI; Applied Energetics, Inc., Tuscon, AZ; Arnouse Digital 
Devices, Corp., Lake Success, NY; Autonomous Defense Technologies Corp. 
(Swarm Aero), Oxnard, CA; Beacon Industries, Inc., Newington, CT; 
Beehive Industries, LLC, Englewood, CO; Bering Global Solutions, LLC, 
Anchorage, AK; Black River Systems Company, Inc., Utica, NY; Brown 
Technologies, Inc., Huntsville, AL; Compotech, Inc., Brewer, ME; Desert 
Tech LLC, West Valley City, UT; Disablement Technologies and Consulting 
LLC, Fredericksburg, VA; ECS Federal, LLC, Fairfax, VA; Falcon Dancer 
Incorporated, Huntsville, AL; Hunting Titan, Inc., Pampa, TX; InDyne, 
INC., Sterling, VA; Marvell Government Solutions, LLC, Burlington, VT; 
Michigan Technological University, Houghton, MI; R. Stresau Laboratory, 
Inc., Spooner, WI; Signature Solutions, Inc., Huntsville, AL; Task 
Aerospace, Inc., Mesa, AZ; TMC Design, Corp., Las Cruces, NM; Trusted 
Semiconductor Solutions, Inc., Brooklyn Park, MN; and Wave Motion 
Launch Corp., Everett, WA, have been added as parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and NAC intends to file additional 
written notifications disclosing all changes in membership.
    On May 2, 2000, NAC filed its original notification pursuant to 
section 6(a) of the Act. The Department of Justice published a notice 
in the Federal Register pursuant to section 6(b) of the Act on June 30, 
2000 (65 FR 40693).
    The last notification was filed with the Department on April 10, 
2023 . A notice was published in the Federal Register pursuant to 
section 6(b) of the Act on June 12, 2023 (88 FR 38098).

Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2023-20772 Filed 9-25-23; 8:45 am]
BILLING CODE P
In the matter of adopting the Infrastructure 

SIP Certification for the 2008 Lead National 

Ambient Air Quality Standard into the 

Washington State Implementation Plan 

SIP ADOPTION ORDER 

The Washington State Department of Ecology (Ecology) offered the public an oppmtunity to 

request a hearing and comment on the draft Infrastructure SIP Certification for the 2008 

Lead National Ambient Air Quality Standard (NAAQS). We did not receive a request to hold 

a public hearing. We accepted comments fi:om February 14, 2014, through March 24,2014. The 

SIP Certification details Washington's capacity to implement, enforce, and maintain the 2008 

NAAQS for lead, and will revise the Washington State Implementation Plan. 

Ecology met all state and federal procedural requirements for public outreach by taking the 

following actions: 

• :Published a legal notice in one newspaper on February 14, 2014. This allowed Ecology to 

meet the requirement for 31 days of advance notice to request a hearing. 

• Issued a news release on February 14, 2014. 

• Announced the public comment period and public hearing date on our online public 

involvement calendar. 

• Published notice on our website. 

• Provided and opportunity for the public to request a hearing by March 17,2014. We did 

not receive a request for a hearing, so we did not hold one, as allowed by 40 CPR Section 

51.102. 

IT IS HEREBY ORDERED that the referenced document, constituting the revision, is 

approved and adopted by the Depal1ment ofEcology as part of the Washington State 

Implementation Plan. All provisions of the Washington State Implementation Plan inconsistent 

with the attached documents are superseded. 

Maia D. Bellon, Director 

Department of Ecology 

~/L /L4 

Date r I
[Federal Register Volume 88, Number 184 (Monday, September 25, 2023)]
[Notices]
[Page 65696]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-20695]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Research and Development of 
Vaccines and Monoclonal Antibodies for Pandemic Preparedness 
(ReVAMPP) Centers for Flaviviridae and Togaviridae (U19 Clinical 
Trial Not Allowed).
    Date: October 24-25, 2023.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3F30, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Scott Jakes, Ph.D., Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, 
National Institute of Allergy and Infectious Diseases, National 
Institutes of Health, 5601 Fishers Lane, Room 3F30, Rockville, MD 
20852, (240) 669-5931, <a href="/cdn-cgi/l/email-protection#2c464d47495f5f496c414d454002424544024b435a"><span class="__cf_email__" data-cfemail="771d161c12040412371a161e1b59191e1f59101801">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: September 20, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-20695 Filed 9-22-23; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
No. 561, Misc.

#### Sanford *v.*Superior Court of Los Angeles County.

Supreme Court of California. Certiorari denied.
From: ncramblit@comcast.net

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 1:56:35 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Nancy Cramblit

Elmhurst, IL 60126
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF CCA PRISON REALTY TRUST FOR THE OTHER ENDED JUNE 30,
1997 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1
       
<S>                             <C>
<PERIOD-TYPE>                   OTHER
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             APR-23-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                           1,000
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 1,000
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                   1,000
<CURRENT-LIABILITIES>                        1,250,000
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         1,000
<OTHER-SE>                                  (1,250,000)
<TOTAL-LIABILITY-AND-EQUITY>                     1,000
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                         0
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
EXHIBIT 32.1

          CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
           PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Guangwen He, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

     (1)  the Annual Report on Form 10-K of HQ Global Education Inc. for the
          year ended August 31, 2010 (the "Report") fully complies with the
          requirements of Section 13(a) or 15(d) of the Securities Exchange Act
          of 1934; and

     (2)  the information contained in the Report fairly presents, in all
          material respects, the financial condition and results of operations
          of HQ Global Education Inc.

Dated: November 29, 2010
                                        /s/ Guangwen He
                                        ----------------------------------------
                                        Chief Executive Officer
                                        (Principal Executive Officer)

A signed original of this written statement required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the electronic version of this written statement
required by Section 906, has been provided to HQ Global Education Inc. and will
be retained by HQ Global Education Inc. and furnished to the Securities and
Exchange Commission or its staff upon request.
Exhibit 32.1


Certification
of Principal Executive Officer


Pursuant
to 18 U.S.C. Section 1350


As Adopted Pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002




Pursuant
to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of
section 1350, chapter 63 of title 18, United States Code), the undersigned
officer of Noble Medical Technologies, Inc., a Delaware corporation (the
“Company”), does hereby certify, to such officer’s knowledge, that:





The
Annual Report on Form 10-K for the period ended December 31, 2008 of the Company
(the “Form 10-K”) fully complies with the requirements of Section 13(a) or 15(d)
of the Securities Exchange Act of 1934, as amended, and the information
contained in the Form 10-K fairly presents, in all material respects, the
financial condition and results of operations of the Company.




Date: February
2, 2009




/s/Richard
      KrutosikRichard
      KrutosikPresident
      and Chief Executive Officer(Principal
      Executive Officer and Principal Financial
  Officer)